Christopher R. Holroyd
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.
Journal: Rheumatology advances in practice
Published: June 26, 2025
Parent-Offspring Associations in Body Composition: Findings From the Southampton Women's Survey Prospective Cohort Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 07, 2022
Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: October 18, 2021
Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
Journal: Rheumatology advances in practice
Published: October 05, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.
Journal: Clinical medicine (London, England)
Published: May 07, 2020
Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review.
Journal: Rheumatology and therapy
Published: March 24, 2020
Rheumatoid arthritis in the elderly: Characteristics and treatment considerations.
Journal: Autoimmunity reviews
Published: January 09, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
Journal: BMC musculoskeletal disorders
Published: July 03, 2019
Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?
Journal: Scandinavian journal of rheumatology
Published: November 17, 2018
Last Updated: 09/26/2026